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Summary 
Mouse lymphocytes were exposed in vitro for 2 h or in vivo for 24 h to benzidine and related aromatic 
amines to test for chromosome aberrations (CA) and mitotic indices. Uninduced mouse $9 was used to 
activate the amines for the in vitro tests to be consistent with the in vivo tests. Contrary to a previous 
report, no difference could be established in the genotoxicity of benzidine following activation with 
uninduced $9 compared to induced $9. There were concentration related increases in CA for benzidine 
and all the amines in vitro except for 4,4'-diaminostilbene which exhibited the greatest cellular toxicity 
towards cultured lymphocytes. Benzidine and its derivatives showed significant increases in CA in vivo 
compared to its negative control. The CA values for 4-aminostilbene were significantly higher than the 
other amines in both in vivo and in vitro studies. These genotoxicity results for 4-aminostilbene are 
consistent with our previous report of the pronounced CA effects in murine bone-marrow cells but would 
not be predicted from Salmonella mutagenicity tests. 
Benzidine, because of its bifunctionality and in 
the case of dyes because of its contribution of 
extending conjugated unsaturation, was an impor- 
tant intermediate in the polymer and dye indus- 
tries. However, the restrictions on its continued 
manufacture and use since its recognition as a 
human carcinogen (Zavon et al., 1973; Haley, 
1975) has led to the utilization of benzidine 
analogs. Therefore, we have been interested in 
developing structure-genotoxicity relationships 
* Corresponding author. 
for aromatic amines related to benzidine to aid in 
making risk assessments of such analogs (Messerly 
et al., 1987; Sinsheimer et al., 1992; You et al., 
1993). In these studies, it was indicated using the 
Ames Salmonella test that mutagenicity in vitro 
was promoted by increases in the electron- 
withdrawing ability of substituents on 4-amino- 
biphenyl, 4-aminostilbene and 3,3'-disubstituted 
benzidine derivatives. However, the results with 
bacteria were not predictive of genotoxicity in 
vivo, as followed by chromosomal aberrations 
(CA) in murine bone-marrow cells following in- 
traperitoneal (i.p.) administration of these aro- 
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matic amines. The most genotoxic compounds in 
vivo were the conjugated amines without sub- 
stituents in the para' position. For example, 4- 
aminostilbene had exceptionally high CA values 
in vivo which would not have been predicted from 
the in vitro mutagenicity data. 
It is the purpose of the present investigation to 
extend such studies of the genotoxicity of benzi- 
dine and its derivatives by using the same mam- 
malian end-point in vitro and in vivo. In this 
manner it should be possible to avoid comparing 
in vitro bacterial to in vivo mammalian results in 
establishing relative genotoxicity in our series of 
aromatic amines. 
The testing for chromosomal effects in the 
blood lymphocytes of humans following occupa- 
tional chemical exposure is well established 
(Lambert et al., 1982; Galloway et al., 1986). 
Methods have also been developed to follow 
chromosomal damage in peripheral blood lym- 
phocytes of rodents following exposure to chemi- 
cals in vivo (Kligerman et al., 1982; Rithdech et 
al., 1987). Cultured human blood lymphocytes 
after in vitro exposure to chemicals have also 
been examined for chromosomal damage in the 
absence of $9 activation (Norppa et al., 1981; 
Sasiadek et al., 1991) and in the presence of $9 
activation (Asquith et al., 1985). 
However, we have not been able to find direct 
comparisons in lymphocytes of chromosomal 
damage following in vitro versus in vivo exposure 
to chemicals in laboratory animals. We have pre- 
viously made that type of comparison for a series 
of direct-acting epoxide mutagens (Das et al., 
1993). In the present study, we needed to extend 
this approach to a series of aromatic amines that 
require metabolic activation prior to exhibiting 
genotoxicity in vitro. A useful starting point for 
this study is the work of Asquith et al. (1985) 
where liver $9 fractions were used with the pro- 
mutagen benzidine to study CA effects in cul- 
tured lymphocytes. Thus, in the present investiga- 
tion, in addition to benzidine, 4-aminobiphenyl, 
4-amino-4'-nitrobiphenyl, 4-aminostilbene, 4,4'- 
diaminostilbene and 4-amino-4'-nitrostilbene 
were examined for CA in mouse lymphocyte cul- 
tures following direct in vitro exposure of the 
amines to the cultures as well as in lymphocyte 
cultures prepared from mice subsequent to the 
i.p. administration of these amines. The relative 
genotoxicity of these amines in vitro compared to 
that in vivo is of primary interest. 
Materials and methods 
Animals 
Male C57BL/6J mice (2-4 months old; 25-30 
g) were obtained from Jackson Laboratory (Bar 
Harbor, ME) and were provided rodent lab chow 
(Purina) and water ad libitum. They were kept 5 
per cage and housed 4-5 days prior to the start of 
the experiment. Ambient temperature of the ani- 
mal room was controlled at 72-74°F with relative 
humidity of 25-50% and a 12-h photoperiod (light 
cycle 0600-1800 h). Bedding consisted of steril- 
ized hardwood chips (Bed-O'-cobs, Anderson In- 
dustrial Products Division, Maumee, OH). 
Chemicals 
Cyclophosphamide monohydrate (6055-19-2) 
(CP) and N-acetylaminofluorene (53-96-3) were 
purchased from Sigma Chemical Co. (St. Louis, 
MO). Dimethyl sulfoxide (DMSO, 99.9%) and 
4-aminobiphenyl (92-67-1) were obtained from 
Aldrich Chemical CO. (Milwaukee, WI). Benzi- 
dine (4,4'-diaminobiphenyl) (92-87-5) was pur- 
chased from Harleco (Philadelphia, PA). 4- 
Amino-4'-nitrobiphenyl (1211-40-1) as well as 4- 
amino-4'-nitrostilbene (7297-52-1), 4-aminostil- 
bene (4309-66-4) and 4,4'-diaminostilbene (7314- 
06-9) were synthesized as described earlier 
(Sinsheimer et al., 1992). 
Lymphocyte assays following in vivo exposure 
Amines (25 mg/kg  body weight) dissolved in 
DMSO (2 ml/kg) were injected i.p. into mice. 
Because of cell toxicity, 4-aminostilbene was also 
tested at 10 mg/kg. Negative control mice re- 
ceived only DMSO (2 ml/kg) and positive con- 
trol mice were injected with CP (25 mg/kg  in 
DMSO). 3 mice were used for each test com- 
pound and for the controls with 2 culture tubes 
prepared from each animal. After 24 h, mice 
were anesthetized with Metafane (metho- 
xyflurane; Pitman-Moore, Washington, NJ) and 
blood was drawn by cardiac puncture. Culture 
tubes were prepared just before inoculation with 
blood (0.2 ml) following the method of Davisson 
and Akeson (1987). Each culture tube contained 
0.95 ml of supplemented medium, 0.15 ml fetal 
bovine serum (Gibco, Gaithersburg, MD), 0.1 ml 
of lipopolysaccharide (50/zg/ml;  Sigma) and 0.15 
ml of purified phytohemagglutinin (60 #g /ml ;  
Burroughs Wellcome, Greenville, NC). Supple- 
mented medium was prepared with 100 ml of 
medium (RPMI 1640; Gibco), 1.2 ml of 200 mM 
L-glutamine (Gibco) and 1 ml of a mixture of 
penicillin (100 IU/ml )  and streptomycin (100 
/~g/ml) (Irvine Scientific, Santa Ana, CA). 
After inoculation with blood, the tubes were 
incubated for 42 h in a humidified 5% CO 2 
atmosphere at 37°C. Colcemid (0.3 /zg, Sigma) 
was added 2-3 h before hypotonic treatment with 
KCI (0.075 M for 20 min). Then the cells were 
fixed in acetic acid:methanol (1:3). Samples of 
cell suspensions were added to precleaned slides, 
air-dried and chromosomes stained with diluted 
Giemsa (1:20) and evaluated by a single observer. 
A total of 100 well-spread metaphase figures (50 
cells per tube) with 40 + 2 chromosomes per ani- 
mal were scored according to the criteria of Car- 
rano and Natarajan (1988). Chromosome and 
chromatid aberrations were scored separately and 
the total percentage of abnormal cells was ex- 
pressed for statistical analysis (Sharief et al., 
1986). Gaps were recorded but not included in 
the total CA frequency. Mitotic indices (MI) were 
estimated from 1000 cells/animal and expressed 
as percentages. Test chemicals and their controls 
were run under the same conditions at the same 
time. Results for the amines were compared to 
those of their controls using Student's t test. 
Lymphocyte assays following in vitro exposure 
Blood was drawn from untreated male mice 
and added to culture tubes as described above. 
$9 was prepared from the livers of 5 male mice 
(C57BL/6J) and the $9 mix made according to 
the method of Maron and Ames (1983). For 
benzidine, the activation treatment was both with 
Aroclor 1254-induced $9 and uninduced $9 mix. 
All the other amines were treated only with unin- 
duced $9. After 21 h, the original medium was 
replaced with fresh serum-free medium contain- 
ing 10% of the mouse $9 mixture. Test amines in 
DMSO (0.01 ml /ml  medium) were added at the 
concentrations indicated in Table 1. After expo- 
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sure for 2 h with the chemicals in the presence of 
$9, the cultures were washed 3 times with fresh 
medium and incubated again for 20 h under the 
same conditions as used for the cell cultures 
obtained following in vivo administration of 
amines. Culture tubes (2 from each of 3 animals) 
were prepared for each concentration of the 
amines and for the controls. The negative control 
was DMSO (0.01 ml /ml  medium) and the posi- 
tive control was N-acetylaminofluorene (100/zg/  
ml). Scoring and analysis of CA results were as 
described above for the in vivo exposure experi- 
ments. Results at each concentration were com- 
pared to those of their negative control using 
Dunnett's test. 
Results and discussion 
The in vitro assay results for benzidine follow- 
ing activation by $9 with and without induction by 
Aroclor 1254 are given in Table 1. Asquith et al. 
(1985), in their study of CA in human lymphocyte 
cultures, reported a greater response for activa- 
tion with uninduced $9 than for induced $9. In 
the present study with mouse lymphocytes, a con- 
centration-response relationship was found with 
both treatments but they were not significantly 
different. All subsequent in vitro comparisons of 
the amines to benzidine were performed with 
uninduced $9 to parallel our in vivo tests. The 
results are given in Table 1. Benzidine and its 
derivatives, except for 4,4'-diaminostilbene, pro- 
duced a significant increase (p < 0.01) in the 
percentage of CA compared to their negative 
controls and concentration-response relation- 
ships could be established for most of these 
amines. However, toxicity at the higher concen- 
trations is a factor in narrowing this relationship 
for 4-aminostilbene and the two nitro com- 
pounds. Toxicity became most evident when these 
compounds were tested at 400/zg /ml  and there 
were insufficient metaphase cells for evaluation. 
4-Aminostilbene exhibited this toxicity at 200 
/zg/ml and 4,4'-diaminostilbene even at 2 5 / z g /  
ml. This latter compound was the only derivative 
for which CA and MI results could not be estab- 
lished. Toxicity is a limitation in ranking these 
amines by the in vitro lymphocyte assay in com- 
parison to our previous study (Sinsheimer et al., 
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TABLE 1 
CHROMOSOMAL ABERRATIONS IN MOUSE LYMPHOCYTE IN VITRO CULTURES INDUCED BY BENZIDINE AND 
RELATED AMINES 
Treatment Gaps a Aberrations/cell  Aberrant cells b Slope c Mitotic indices 
Dose Chromatid Chromosome (%) (mean + S.D.) d (r 2) (%) (mean 5: S.D.) d 
( /xg/ml)  type type 
Induced $9 
Solvent control 






































3.33 0.020 0.000 2.00 + 1.00 2.16 _+ 0.27 
4.00 0.030 0.013 4.33+0.58 ** 0.017 1.55+0.26 ** 
6.67 0.047 0.010 5.67 + 1.15 5:0.002 1.41 + 0.35 
9.00 0.050 0.047 9.00 + 1.00 (0.91) 1.25 + 0.45 
6.33 0.043 0.007 5.00+0.00 ** 1.50_+0.41 ** 
3.00 0.020 0.000 2.00 _+ 1.00 2.23 __+ 0.37 
3.33 0.026 0.013 4.00+1.00 ** 0.016 1.69-+0.50 ** 
6.33 0.047 0.017 6.00 -+ 1.00 + 0.002 1.45 + 0.21 
7.67 0.056 0.027 8.33 5:0.58 (0.89) 1.29 _+ 0.28 
4.67 0.026 0.020 4.67 + 0.58 * * 0.039 1.75 _+ 0.26 * 
6.33 0.053 0.017 6.33_+1.15 _+0.004 1.54_+0.46 ** 
8.33 0.063 0.043 10.00 + 1.00 (0.92) 1.17 + 0.30 
4.33 0.044 0.000 4.33+0.58 ** 0.024 1.57_+0.20 ** 
5.33 0.047 0.007 5.33 + 0.58 _+ 0.004 1.48 + 0.35 
6.67 0.053 0.017 7.00 + 1.00 (0.82) 1.27 + 0.41 
7.00 0.053 0.023 7.67+0.58 ** 0,083 1.51-+0.25 ** 
9.33 0.077 0.030 10.33 + 0.58 -+ 0.016 1.38 + 0.22 
12.33 0.080 0.033 11.00_+ 1.00 (0.72) 1.11+0.31 
cell toxicity 
insufficent metaphase cells 
cell toxicity - -  no division 
0.82 -+ 0.24 * * 
5.33 0.043 0.010 5.33_+0.58 ** 0.026 1.55+0.26 ** 
7.33 0.060 0.000 6.00 _+ 1.00 _+ 0.005 1.43 _+ 0.14 
7.00 0.077 0.000 7.67+ 1.15 (0.74) 1.28-+0.22 
4.33 0.040 0.013 5.33_+1.66 ** 1.43_+0.17 ** 
a Total chromatid and chromosome gaps per 100 cells at each concentration were recorded but not included as aberrations. 
b Cells with at least 1 aberration. Results are for 3 animals at each concentration (100 cells/animal from 2 culture tubes). 
c Slope + S.D. and correlation coefficent (r E) for the aberrant cell concentration-response curve for each compound. 
d Lowest dose for which the mean is significantly greater than its negative control using Dunnett 's test is indicated by * P < 0.05 
and * * P < 0.01. 
1992) in which Salmonella strains were used and 
4,4'-diaminostilbene was found to be weakly mu- 
tagenic. 
CA frequencies and MI values for the lympho- 
cytes of mice following i.p. administration of ben- 
zidine and the 5 related aromatic amines were 
observed at a single dose of 25 mg/kg  for an 
initial comparison of their in vivo genotoxicity. 
This dose was based upon the previous dose- 
genotoxicity relationships found for benzidine in 
our in vivo CA bone-marrow cell study 
(Sinsheimer et al., 1992). The fixation times used 
for the lymphocyte cultures in this study are the 
same as those previously employed in our epox- 
ides study (Das et al., 1993). DeBoer et al. (1977) 
found for murine lymphocytes that similar fixa- 
tion times resulted in predominantly 1st division 
metaphase cells. For a more definitive in vivo 
genotoxicity comparison, an optimal fixation time 
should be established for these compounds and 
the comparison should be based upon a dose-re- 
sponse evaluation for each compound (Preston et 
al., 1987). 
In the present in vivo CA assay, all the com- 
pounds with the exception of 4-aminostilbene had 
a significant increase in the percentage of abnor- 
mal cells at 25 mg/kg  when compared to the 
negative control (1.67 + 0.58%). 4-Aminostilbene 
could not be compared at this concentration be- 
cause of cell toxicity but at 10 mg/kg  it had a 
higher percentage of CA (7.00 + 1.00%) than any 
of the other amines at 25 mg/kg  (3.00 + 1.00- 
5.67+ 1.16%), where for these values 4,4'-di- 
aminostilbene had the least and 4-amino-4'- 
nitrostilbene had the greatest genotoxicity. These 
results are in comparison to 11.00 + 1.00% for 
CP, the positive control. The most frequent aber- 
rations were chromatid breaks. Benzidine and all 
5 aromatic amines produced a significant de- 
crease in MI compared to the negative solvent 
control. 
The results of the present studies on cultured 
mouse lymphocytes subsequent to either in vivo 
or in vitro exposure to the aromatic amines were 
compared to our previous in vivo genotoxicity 
studies of the same amines (Sinsheimer et al., 
1992). In general, there is an increase in observ- 
able results for the in vivo lymphocyte assay com- 
pared to the in vivo bone-marrow cell examina- 
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tion for CA. That is, CA values for 25 mg/kg  i.p. 
doses in the lymphocyte assay are about twice 
those of the bone-marrow cell results at this dose. 
These results for the non-dividing lymphocytes in 
comparison to rapidly dividing bone-marrow cells 
were unexpected. 
The relative order of in vitro lymphocyte geno- 
toxicity is 4-aminostilbene > 4-aminobiphenyl > 
4-amino-4'-nitrostilbene = 4-amino-4' nitrobiphen- 
yl > benzidine. Thus, 4-aminostilbene is the most 
genotoxic of the present series of amines when 
the same lymphocyte-CA end point was used in 
vitro and in vivo. This was not the case when 
Salmonella strains were used for the in vitro 
evaluation of these amines. Moreover, the pre- 
sent study is in agreement with the pronounced 
in vivo genotoxicity of 4-aminostilbene as mea- 
sured by its CA effects to the bone-marrow cells 
of mice. 
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